Abstract:STUDY QUESTION Does basic fibroblast growth factor (bFGF) in combination with fibrin hydrogel improve follicle development and revascularization of heterotopically transplanted mouse ovarian tissues? SUMMARY ANSWER Treatment of transplanted ovarian tissues with higher concentrations (75, 100 and 150 μg/ml), but not lower concentrations (25 and 50 μg/ml), of bFGF significantly improved primordial follicle survival and angiogenesis, while apoptosis of follicles and stromal cells was significantly decreased. WHAT IS KNOWN ALREADY Use of transplanted ovarian tissues in female fertility preservation is limited by the massive loss of follicles and ischemia-reperfusion injury due to the expected delay in revascularization. STUDY DESIGN, SIZE AND DURATION Ovarian tissues from 18-day-old ICR mice were encapsulated in ﬁbrin hydrogel mixed with different concentrations of bFGF, then transplanted under the skin of adult female mice for 1 week. The ovarian tissues treated without fibrin hydrogels and bFGF were designated as Control group I, and the ovarian tissues treated with fibrin hydrogels but without bFGF were designated as Control group II. The ovarian tissues treated with 25 and 50 μg/ml bFGF were designated as the lower concentration group, and the ovarian tissues treated with 75, 100 and 150 μg/ml bFGF were designated as the higher concentration group. MATERIALS, SETTING AND METHODS Assessment of follicular quantity and follicle classification was carried out by histologic analysis. Follicle proliferation was evidenced by immunostaining with proliferating cell nuclear antigen and apoptosis was verified by anti-active caspase-3 staining. Epithelial cells of new blood vessels were stained using CD31 antibody to evaluate neoangiogenesis, and the blood vessel density was analyzed by immunohistochemistry. MAIN RESULTS AND THE ROLE OF CHANCE The ovarian tissues were recovered 1 week post-transplantation. Compared with the control group, the survival and proliferation of the follicles was significantly increased, the apoptosis of follicles and stromal cells was significantly decreased, and angiogenesis was significantly enhanced when the transplanted ovarian tissues were treated with a higher concentration of bFGF. Treatment with a lower concentration of bFGF did not improve follicle survival and blood revascularization. LIMITATIONS, REASONS FOR CAUTION The results obtained may not be fully extrapolated to humans because of the physiologic differences between mice and humans. WIDER IMPLICATIONS OF THE FINDINGS For the first time, the present study investigated the role of bFGF in transplanted ovarian tissues and demonstrated that bFGF might significantly improve the quality of transplanted ovarian tissues by increasing follicle quantity and promoting neoangiogenesis. This study sets the stage for further study and application of ovarian tissue transplantation in clinics, and may eventually benefit females for fertility preservation. STUDY FUNDING/COMPETING INTEREST(S) This work was partially supported by the Ministry of Science and Technology of China Grants (973 Program; 2011CB944503 to Q.J.), the Program for Changjiang Scholars and Innovative Research Team in University of Ministry of Education of China (30825038 to Q.J.), and the National Natural Science Funds for Young Scholar (81200470 to Y.J. and 81000275 to Y.L.Y.). None of the authors have any conflicts of interest.

The Revascularization and Follicular Survival of Mouse Ovarian Grafts Treated with FSH During Cryopreservation by Vitrification.

The Increased Expression of Connexin and VEGF in Mouse Ovarian Tissue Vitrification by Follicle Stimulating Hormone

Roles of follicle stimulating hormone and sphingosine 1-phosphate co-administered in the process in mouse ovarian vitrification and transplantation

Morphology and Cell Proliferation Evaluation of Follicles from Cryopreserved Human Ovarian Tissue by Vitrifiction and Slow-cooling

Optimal FSH Usage in Revascularization of Allotransplanted Ovarian Tissue in Mice

The Influence of FSH Interpose on the VEGF and VEGFR-2 Expression in the Different Stage of Mouse Ovary Vitrification

Exogenous Luteinizing Hormone Promotes Ovarian Survival and Function During Cryopreservation and Transplantation

Bfgf and VEGF Improve the Quality of Vitrified-Thawed Human Ovarian Tissues after Xenotransplantation to SCID Mice

Effect of Local Basic Fibroblast Growth Factor and Vascular Endothelial Growth Factor on Subcutaneously Allotransplanted Ovarian Tissue in Ovariectomized Mice.

VEGF and Bfgf Increase Survival of Xenografted Human Ovarian Tissue in an Experimental Rabbit Model

Effects of Cryopreservation on Mouse Ovarian Tissue after Vitrification

Effects of Two Cryoprotectants on Mouse Ovarian Tissue after Vitrification

Fertility restore of allotransplantation of vitrified-warmed junvenile ovaries treated with a modified vitrification solution

Improvement in the Quality of Heterotopic Allotransplanted Mouse Ovarian Tissues with Basic Fibroblast Growth Factor and Fibrin Hydrogel.

High FSH levels impair VEGF secretion of human, frozen-thawed ovarian cortical tissue in vitro

Vascular endothelial growth factor expression and angiogenesis in human ovarian tissue after different cryopreservations

The Effects of VEGF and bFGF on Ovarian Tissue Transplantation in Mice

Assessment of apoptosis and oxidative stress in cryopreserved ovary after grafting in fibrin-alginate scaffold with endothelial cells and melatonin in wistar rats

Transplantation of intact rat gonads using vascular anastomosis: effects of cryopreservation, ischaemia and genotype

Experimental Study on the Vitrification and Xenotransplantation of Human Ovarian Tissue

Evaluation of Vitrification Protocol of Mouse Ovarian Tissue by Effect of DNA Methyltransferase-1 and Paternal Imprinted Growth Factor Receptor-Binding Protein 10 on Signaling Pathways